Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton. - Bogdanos,J.; Karamanolakis,D.; Tenta,R.; Tsintavis,A.; Milathianakis,C.; Mitsiades,C.; Koutsilieris,M. (Endocr Relat Cancer, 2003)